PATENT CLAIM ANALYSIS

Application Number: 16289451
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "005400"]

Abstract:
The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Claim (Index 21):
The method of  claim 1 , wherein the peptide is: Isovaleric acid-DTHFPCIKF(K(PEG3-Palm))PRSKGWVCK-NH 2  (SEQ ID NO:223).

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775469', '15828214', '16037982', '14800627', '15442229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8801572436808783
- 35 USC 102 Novelty (BERT): 0.7089705848718058
- Combined Prediction Score: 0.8630385777999711
- Mean Citation Score: 708.0968359999997
- Max Citation Score: 889.48676
- Similarity Product: 781.0384757998729

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test